Table 2.
T2DM Subjects (n = 36) | Non-Diabetic Subjects (n = 27) | p-Value | |
---|---|---|---|
Total VLDL (nmol/L) | 68.9 (48.6–82.1) | 58.7 (51.4–86.7) | 0.56 |
Large VLDL (nmol/L) | 6.8 (2.8–9.9) | 2.9 (2.3–4.7) | 0.035 |
Medium VLDL (nmol/L) | 23.0 (15.8–40.6) | 24.8 (12.5–38.2) | 0.45 |
Small VLDL (nmol/L) | 29.9 (20.2–42.9) | 32.2 (21.1–44.3) | 0.51 |
Total LDL (nmol/L) | 1257 (1022–1540) | 981 (856–1284) | 0.004 |
IDL (nmol/L) | 170 (118–234) | 188 (140–257) | 0.14 |
Large LDL (nmol/L) | 509 (345–612) | 469 (435–597) | 0.57 |
Small LDL (nmol/L) | 586 (400–850) | 338 (149–442) | 0.003 |
Total HDL (µmol/L) | 32.9 (29.3–37.9) | 33.8 (32.0–36.1) | 0.75 |
Large HDL (µmol/L) | 5.0 (2.6–6.6) | 6.7 (4.6–9.9) | 0.021 |
Medium HDL (µmol/L) | 10.1 (8.3–14.4) | 12.8 (11.5–16.1) | 0.007 |
Small HDL (µmol/L) | 17.7 (14.6–20.9) | 14.3 (10.1–16.30 | 0.006 |
Data are expressed in medians (interquartile ranges). Abbreviations: VLDL: very low density lipoproteins; LDL low density lipoproteins; IDL: intermediate density lipoproteins; HDL: high density lipoproteins. Differences between subjects with and without T2DM were determined by T-tests using loge transformed values.